265 results
8-K
EX-99.1
AZTA
Azenta Inc
7 Feb 24
Results of Operations and Financial Condition
4:21pm
offset by a year-over-year decline in the C&I business. Excluding the C&I business, the segment grew 9% on an organic basis.
Multiomics revenue was $63 … services, partially offset by a year-over-year decline in Sanger sequencing revenue.
B Medical Systems revenue was $13 million, down 70% year over year
8-K
EX-99.1
AZTA
Azenta Inc
13 Nov 23
Results of Operations and Financial Condition
4:30pm
offset by continued softness in C&I. Excluding the C&I business, the products segment grew 21% year over year on an organic basis.
Life Sciences Services … basis points year over year. A lower B Medical margin was partially offset by cost reduction initiatives within operations and favorable product mix
8-K
EX-99.1
ukoibm
9 May 23
Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment
4:12pm
DEFA14A
3kxdrq40k8741xa9foci
21 Dec 22
Additional proxy soliciting materials
4:07pm
8-K/A
EX-99.3
7x99 gbsgklhln8d8
15 Dec 22
Financial Statements and Exhibits
4:52pm
8-K
EX-10.1
l1hjqnve5wpzii4hf8
23 Nov 22
Azenta Announces $500 Million Accelerated Share Repurchase Agreement
7:45am
8-K
EX-99.1
fcwal6fq64 9p
14 Nov 22
Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program
4:44pm
8-K
EX-99.1
n8v 00cmwymv4j0
9 Aug 22
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
6iagnae57n6 nzvkjbv
9 May 22
Robust customer demand bolstered by operational execution drives strong second quarter results
4:11pm
8-K
EX-99.1
ei304zwzoig1tj1nu
8 Feb 22
Continued Double-Digit Growth, Healthy End Markets, and a Strong Balance Sheet
4:17pm